Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Novo Nordisk says Victoza outperforms SGLT2 inhibitors

Novo Nordisk says Victoza outperforms SGLT2 inhibitors drugs. . It compared Victoza to the three marketed SGLT2 inhibitors - Johnson &Johnson's Invokana (canagliflozin), Lilly/Boehringer's Jardiance (empagliflozin) and AstraZeneca's Farxiga (dapagliflozin). . ... Novo Nordisk has its own cardiovascular

Novo Nordisk finally bags insulin degludec approval in US

Novo Nordisk finally bags insulin degludec approval in US agonist that can be given by subcutaneous just once a week while most rivals – including its own Victoza (liraglutide) product – are dosed every day.

Sanofi's lixisenatide is back under FDA review

Sanofi's lixisenatide is back under FDA review In the interim Novo Nordisk's rival Victoza (liraglutide) has firmly established itself at the top of the GLP-1 agonist tree, with sales of around $2bn a year.

New data arms Novo Nordisk for insulin battle with Sanofi

New data arms Novo Nordisk for insulin battle with Sanofi Meanwhile, the results of the DUAL trial of recently-launched combination product Xultophy - which combines insulin degludec with Novo's GLP-1 agonist Victoza (liraglutide) - showed greater improvements in treatment-related

Sanofi plans LixiLan filings after positive phase III trial

Sanofi plans LixiLan filings after positive phase III trial Sanofi's product featuring the world's biggest-selling basal insulin while Novo Nordisk's drug incorporates the top-selling GLP-1 agonist Victoza. Similarly, while Sanofi's lixisenatide was delayed

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics